Wang Y - Search Results

1

Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines.

Zang Y, Du D, Li N, Su W, Liu X, Zhang Y, Nie J, Wang Y, Kong W, Jiang C. Zang Y, et al. Among authors: wang y. Vaccine. 2015 Jul 31;33(32):3859-64. doi: 10.1016/j.vaccine.2015.06.072. Epub 2015 Jun 28. Vaccine. 2015. PMID: 26126669

2

Impact of HIV-1 genetic diversity in China on the measurement of viral load.

Wang Y, Song A, Xu S, Li X, Chong H, Zhao C, Nie J, Zhang C. Wang Y, et al. J Med Virol. 2008 Jan;80(1):1-8. doi: 10.1002/jmv.21048. J Med Virol. 2008. PMID: 18041045

3

Genetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in China.

Chong H, Hong K, Zhang C, Nie J, Song A, Kong W, Wang Y. Chong H, et al. Among authors: wang y. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):535-43. doi: 10.1097/QAI.0b013e3181663967. J Acquir Immune Defic Syndr. 2008. PMID: 18209676

4

Comparative evaluation of the COBAS AmpliPrep/COBAS TaqMan HIV type 1 test (CAP/CTM) and VERSANT HIV type 1 RNA 3.0 assay (bDNA) for quantifying HIV type 1 viral loads in China.

Xu S, Song A, Nie J, Li X, Li J, Bao Z, Wang Y. Xu S, et al. Among authors: wang y. AIDS Res Hum Retroviruses. 2008 Nov;24(11):1365-73. doi: 10.1089/aid.2008.0005. AIDS Res Hum Retroviruses. 2008. PMID: 18928395

5

Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.

Ma H, Song X, Li Z, Harrison TJ, Zhang H, Huang W, Hao W, Kong W, Wang Y. Ma H, et al. Among authors: wang y. J Med Virol. 2009 Jun;81(6):1052-61. doi: 10.1002/jmv.21484. J Med Virol. 2009. PMID: 19382255

6

Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance.

Chong H, Xu S, Zhang C, Nie J, Wang Y. Chong H, et al. Among authors: wang y. J Clin Virol. 2009 Jul;45(3):255-8. doi: 10.1016/j.jcv.2009.05.001. Epub 2009 May 31. J Clin Virol. 2009. PMID: 19487156

7

Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.

Ma H, Song X, Harrison TJ, Li R, Huang G, Zhang H, Kong W, Wang Y. Ma H, et al. Among authors: wang y. Arch Virol. 2009;154(10):1641-8. doi: 10.1007/s00705-009-0496-4. Epub 2009 Sep 15. Arch Virol. 2009. PMID: 19763777

8

Genotypic and phenotypic characterization of HIV-1 CRF01_AE env molecular clones from infections in China.

Nie J, Zhang C, Liu W, Wu X, Li F, Wang S, Liang F, Song A, Wang Y. Nie J, et al. Among authors: wang y, wang s. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):440-50. doi: 10.1097/QAI.0b013e3181cb8300. J Acquir Immune Defic Syndr. 2010. PMID: 20090544

9

Development and evaluation of a national reference panel of HIV-1 protease and reverse transcriptase drug-resistance mutations for HIV-1 genotypic resistance assays in China.

Xu S, Li J, Bao Z, Xing H, Zhong P, Li H, Zhou H, Li X, Wu S, Song A, Li X, Nie J, Wang Y. Xu S, et al. Among authors: wang y. Mol Diagn Ther. 2010 Feb 1;14(1):31-41. doi: 10.1007/BF03256351. Mol Diagn Ther. 2010. PMID: 20121288

10

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

Zhang T, Xu Y, Qiao L, Wang Y, Wu X, Fan D, Peng Q, Xu X. Zhang T, et al. Among authors: wang y. Vaccine. 2010 Apr 26;28(19):3479-87. doi: 10.1016/j.vaccine.2010.02.057. Epub 2010 Mar 6. Vaccine. 2010. PMID: 20211219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299,541 results

Search Page

Filters